相关实验视频
Updated: Jun 25, 2025

08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.2K
动脉硬和发生慢性病:一个大型基于人口的队列研究
Angela Beros1, John Sluyter1, Alun Hughes2
1School of Population Health, University of Auckland, Auckland, New Zealand.
Journal of nephrology
|May 29, 2024
概括
动脉硬度增加,通过脉冲波速度和脉冲压力来衡量,显著提高患慢性病 (CKD) 的风险. 这些动脉硬度测量可以帮助识别具有未来CKD风险较高的个体.
科学领域:
- 心血管医学 心血管医学
- 腎臟病學 (nephrology) 是一種醫學.
- 流行病学 流行病学
背景情况:
- 在大型人群研究中,关于动脉硬与发生慢性病 (CKD) 之间的关联存在不同的证据.
- 这项研究研究了振荡计评估的动脉硬度与CKD发病率之间的关系.
研究的目的:
- 要确定通过各种措施评估的动脉硬是否与新发慢性病 (CKD) 的发展有关.
- 为了评估动脉硬度参数对发生性CKD在大量人群队列中的预测值.
主要方法:
- 利用了维生素D评估研究 (ViDA) 的4838名参与者的数据,没有事先存在的CKD.
- 通过大动脉脉冲波速度,估计的动脉-大腿脉冲波速度和大动脉脉压来评估动脉硬度.
- 事件CKD通过国家医院出院登记册的链接来确定,使用Cox比例危险回归进行分析.
主要成果:
- 在平均10.5年的随访期间,376名参与者患有事件性CKD.
- 调整后的分析显示了显著的关联:每次SD增加的较高的大动脉脉冲波速率 (HR 1.69),估计的动脉-大腿脉冲波速率 (HR 1.84) 和大动脉脉压 (HR 1.37) 与增加CKD风险有关.
- 所有动脉硬度测量的最高四分位数显示,与最低四分位数相比,发生性CKD的风险明显增加 (P趋势<0.001对所有).
结论:
- 动脉硬度,特别是大动脉脉冲波速度,估计的动脉-大腿脉冲波速度和大动脉脉压,是发生CKD的重要预测因素.
- 这些对动脉硬性的客观测量可以在临床实践中成为有价值的工具,用于识别有未来病风险的个体.
相关概念视频
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Antihypertensive Drugs: Direct Renin Inhibitors
597
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
597
Factors Affecting Renal Clearance: Renal Impairment
86
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
86
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
618
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
618

